Democratizing genomics
Clear Labs democratizes genomic applications to deliver increased clarity.
Clear Labs’ turnkey platform accelerates outcomes and improves accuracy - from food-borne pathogens to infectious diseases, including SARS-CoV-2.
Clear Labs launches groundbreaking solution for surveillance of SARS-CoV-2 and its mutations.
These variants, as well as future mutations, can now be identified in real-time by a revolutionary new rapid WGS workflow solution launching today from Clear Labs, provider of the only fully-automated next-generation sequencing (NGS) platform for turnkey diagnostics.